Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma of Skin”

814 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 814 results

Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Early research (Phase 1)Ended earlyNCT01032122
What this trial is testing

Rituximab in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Medical University of Vienna 9
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06190951
What this trial is testing

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 151
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT00138229
What this trial is testing

Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 6
Testing effectiveness (Phase 2)Study completedNCT06152367
What this trial is testing

Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients

Who this might be right for
Stage III Malignant Melanoma of Skin AJCC V6Stage IV Malignant Melanoma of Skin
University of Chile 90
Early research (Phase 1)Study completedNCT02680184
What this trial is testing

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 199
Testing effectiveness (Phase 2)Study completedNCT00020358
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT05309421
What this trial is testing

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma Stage IVUnresectable Melanoma
Evaxion Biotech A/S 17
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Study completedNCT00110994
What this trial is testing

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
CancerMelanoma
Bayer 101
Testing effectiveness (Phase 2)Study completedNCT00003362
What this trial is testing

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00324623
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Prof. Serge Leyvraz 8
Early research (Phase 1)Study completedNCT02659540
What this trial is testing

Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV Melanoma

Who this might be right for
Melanoma
Ludwig Institute for Cancer Research 20
Large-scale testing (Phase 3)Study completedNCT01006980
What this trial is testing

Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 675
Testing effectiveness (Phase 2)Study completedNCT00036764
What this trial is testing

BMS-247550 in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 88
Not applicableLooking for participantsNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00602576
What this trial is testing

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 169
Large-scale testing (Phase 3)Study completedNCT01584648
What this trial is testing

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 423
Load More Results